Speakers
- Alessandra Blonda, PhD Researcher at KU Leuven Pharmacology and Pharmacotherapy research group and Technical Officer for the Real World Evidence and Artificial Intelligence Interest Group at HTAi
- Thomas Desmet, PhD Researcher at KU Leuven & Vlerick Business School
Host
- Prof. dr. Isabelle Huys, professor Regulatory Sciences at the University of Leuven (Belgium)
Market access of Advanced therapy medicinal products (ATMPs) is key to making innovative and potential curing therapies available for patients. Pricing and reimbursement are organised at the national level, though international initiatives are fundamental, essentially in the context of complex treatments covering ATMPs. This last ADVANCE webinar explain the main market access principles for medicinal products and innovative payment models for ATMP market access.
ADVANCE is an innovative and focused learning programme for future advanced therapies developers. This scientific webinar of the last ADVANCE Webinar series presents an overview of essential aspects of ATMP manufacturing. Find out more here: eatris.eu/proj...